LINC00838

Across TCGA pan-cancer cohorts, LINC00838 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC00838 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC00838 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00838 expression acts as an unfavorable survival marker, although some lineages such as TGCT and UCS show a favorable association.

BLCA, PAAD, and DLBC are the cancer types where LINC00838 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.242	0.524	<.001	162	view →
PAAD	DFS	Tertile	II,III,IV	0.266	0.473	<.001	120	view →
DLBC	OS	Median	All	0.455	1.000	<.001	95	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
MESO	DFS	Tertile	III,IV	0.132	0.384	.006	36	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
CESC	DFS	Tertile	IV	0.163	0.543	.015	36	view →
COAD	OS	Tertile	IV	0.089	0.676	<.001	36	view →
UCEC	OS	Tertile	All	0.878	0.935	.015	30	view →
TGCT	DFS	Tertile	All	0.937	0.686	.001	18	view →
UCS	DFS	Tertile	IV	0.981	0.510	.020	18	view →
KIRP	DFS	Tertile	All	0.813	0.934	.006	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC00838–BLCA (DFS)

Open the BLCA breakdown →